Can't get back above 0 on MACD. Can't get back above 50 on Stoch RSI. TradingNewsNow claims an intrinsic value per share above $130. Results and Presentations seem to not be helping. I'd "like" to see $41/share, but $24/share might be more the direction of Nektar Therapeutics before a rebound. Continuing to watch sideways movements between $30-$37 in the meantime.
Not a broker, nor is this financial advice. I had Nektar hope in opioid replacements for pain therapy and immuno-oncology therapies. I guess they simply cannot beat cannabis in providing quality of life.
Not a broker, nor is this financial advice. I had Nektar hope in opioid replacements for pain therapy and immuno-oncology therapies. I guess they simply cannot beat cannabis in providing quality of life.
Trade active
Lowered Position
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.